查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球电生理学市场（按产品、适应症、最终用户和地区划分）- 预测至 2030 年
市场调查报告书
商品编码
1797403

全球电生理学市场（按产品、适应症、最终用户和地区划分）- 预测至 2030 年

Electrophysiology Market by Product (Lab Devices, Ablation Catheters, Diagnostic Catheters ), End Use-Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 330 Pages | 订单完成后即时交付

价格

预计全球电生理学市场将从 2025 年的 125.5 亿美元成长到 2030 年的 217.2 亿美元，预测期内复合年增长率为 11.6%。

电生理学市场的预期成长将受到技术进步和研究资金增加的推动。

调查范围
调查年份 2024-2030
基准年 2024
预测期 2025-2030
对价单位 金额（十亿美元）
部分 按产品、适应症、最终用户和地区
目标区域 北美、亚太地区、欧洲、中东和非洲、南美

全球向基于价值的护理和早期疗育的转变也推动了诊断性电生理工具（例如植入式循环记录器和可穿戴式心电图设备）的广泛应用。此外，自新冠疫情以来，远端保健的发展改善了远距心律不整监测和后续照护的可近性。政府对心臟计画的投资增加、官民合作关係投资的不断增长，以及人工智慧和机器人导航系统的持续整合，将进一步提高流程的效率和标准化。总体而言，这些因素正在推动全球电生理学市场的强劲扩张。

电生理学市场-IMG1

电生理市场细分为电生理检测设备、电生理消融导管、电气生理学诊断导管、电生理通路产品等。电生理 (EP) 消融导管市场的扩张受多种因素驱动。特别是，全球心房颤动 (AF) 和其他心律不整的发病率正在上升，尤其是在老年人口中，这推动了对有效治疗性介入的需求。此外，导管技术的创新，例如接触力感测、灌注尖端设计和脉衝电场消融，正在提高安全性、准确性和有效性，从而导致电生理学家越来越多地采用这些技术。

依产品类型，电生理学市场分为心房颤动、心房扑动、房室结折返性心动过速 (AVNRT)、预激综合征 (WPW) 和其他适应症。电生理学 (EP) 市场中心心房颤动 (AF) 部分的扩张主要受到人口统计、生活方式、临床和技术的影响。由于全球人口老化、肥胖、高血压、糖尿病和久坐不动的生活方式的增加，AF 的盛行率显着增加。 AF 的负担日益加重，推动了对 EP 诊断和治疗性介入的需求不断增长。此外，EP 程序的重大进展，包括增强的心导管电气烧灼术技术、尖端的映射系统和复杂的心内成像技术，已显着提高介入的有效性和安全性。这些技术创新反映了 AF 治疗的模式转移，鼓励临床医生更早、更频繁地进行消融手术。

北美电生理学领域正在经历强劲扩张，主要原因是心律不整（尤其是心房颤动）的盛行率上升。这一趋势与人口老化以及肥胖、糖尿病和高血压等合併症的高盛行率有关。因此，对先进的诊断和治疗电生理程序的需求正在增长。最近的创新，例如3D电解剖映射、增强射频和冷冻消融技术以及脉衝电场消融的引入，显着提高了手术准确性、患者安全性和临床结果。这些进步正在推动电生理治疗融入标准循环系统工作流程。

预计亚太地区电生理学市场在预测期内将显着成长。该地区包括印度、中国、日本、澳洲、韩国和亚太其他地区等主要市场。由于多种相互关联的因素，亚太地区的电生理学市场正在经历显着的加速发展。包括中国、印度、日本和韩国在内的亚太主要国家的医疗成本不断上涨，促使医疗服务提供者迅速采用先进的医疗技术。医疗基础设施的改善促进了这一转变，使先进的电生理学设备更容易获得。此外，由于老化、都市化和生活方式的改变等人口变化导致心血管疾病盛行率不断上升，凸显了对有效诊断和治疗方法的迫切需求。电生理学程序在评估和管理心臟疾病方面被广泛依赖，从而推动了该地区对相关诊断和治疗设备的需求。

本报告研究了全球电生理学市场，按产品、适应症、最终用户和地区对其进行细分，并提供了参与市场的公司概况。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章市场概述

  • 介绍
  • 市场动态
  • 产业趋势
  • 技术分析
  • 波特五力分析
  • 主要相关人员和采购标准
  • 监管分析
  • 还款情境分析
  • 专利分析
  • 贸易分析
  • 定价分析
  • 2025-2026年主要会议和活动
  • 未满足的需求和最终用户的期望
  • 价值链分析
  • 供应链分析
  • 生态系分析
  • 案例研究分析
  • 邻近市场分析
  • 影响客户业务的趋势/中断
  • 投资金筹措场景
  • 人工智慧/生成式人工智慧对电生理学市场的影响
  • 2025年美国关税对电生理学市场的影响

第六章：电生理学市场（按产品）

  • 介绍
  • 电生理实验设备
  • 电生理消融导管
  • 电气生理学诊断导管
  • 电生理接入设备
  • 其他的

第七章 电生理学市场（按适应症）

  • 介绍
  • 心房颤动
  • 心房扑动
  • 房室结迴旋性心搏过速（AVNRT）
  • 沃尔夫-巴金森-怀特氏症候群（WPW）
  • 其他的

第 8 章：电生理学市场（按最终用户）

  • 介绍
  • 医院和心臟中心
  • 门诊手术中心
  • 其他的

9. 电生理学市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 中东和非洲宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十章 竞争格局

  • 介绍
  • 主要参与企业的策略/优势
  • 2020-2024年收益分析
  • 2024年市场占有率分析
  • 公司估值矩阵：2024 年关键参与企业
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 估值和财务指标
  • 品牌/产品比较
  • 主要参与企业研发评估
  • 竞争场景

第十一章：公司简介

  • 主要参与企业
    • JOHNSON & JOHNSON SERVICES, INC.
    • ABBOTT
    • MEDTRONIC
    • KONINKLIJKE PHILIPS NV
    • GE HEALTHCARE
    • BOSTON SCIENTIFIC CORPORATION
    • JAPAN LIFELINE CO., LTD.
    • STEREOTAXIS, INC.
    • MICROPORT SCIENTIFIC CORPORATION
    • BIOTRONIK
    • TELEFLEX INCORPORATED
    • ACUTUS MEDICAL, INC.
    • MERIT MEDICAL SYSTEMS
    • OSYPKA MEDICAL
    • COOK
  • 其他公司
    • EPMAP-SYSTEM
    • CATHRX LTD.
    • EP SOLUTIONS
    • CATHVISION
    • TZ MEDICAL, INC.
    • APN HEALTH, LLC
    • LEPU MEDICAL TECHNOLOGY（BEIJING）CO.,LTD.
    • CARDIOFOCUS
    • SCHWARZER CARDIOTEK
    • IMRICOR

第十二章 附录

Product Code: MD 3273

The global electrophysiology market is expected to reach USD 21.72 billion by 2030 from USD 12.55 billion in 2025, at a CAGR of 11.6% during the forecast period. The projected growth in the electrophysiology market is driven by technological advancements and increased research funding.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Indication, End User, and Region
Regions coveredNorth America, Asia Pacific, Europe, the Middle East & Africa, and South America

The worldwide shift toward value-based care and early intervention also encourages wider adoption of diagnostic EP tools like implantable loop recorders and wearable ECG devices. Additionally, the growth of telehealth after COVID-19 has improved access to remote arrhythmia monitoring and follow-up care. Increased government investment in cardiac programs, rising investments from public-private partnerships, and ongoing integration of AI and robotic navigation systems further improve procedure efficiency and standardization. Overall, these factors are fueling strong global expansion of the electrophysiology market.

Electrophysiology Market - IMG1

"On the basis of product, the electrophysiology ablation catheters commanded the largest share in the electrophysiology market in 2024."

The electrophysiology market is categorized into several segments: electrophysiology laboratory devices, electrophysiology ablation catheters, electrophysiology diagnostic catheters, EP access products, and additional device types. The expansion of the electrophysiology (EP) ablation catheter sector is propelled by multiple factors. Notably, there is an increasing global incidence of atrial fibrillation (AF) and other cardiac arrhythmias, particularly within aging demographics, which heightens the demand for effective therapeutic interventions. Additionally, innovations in catheter technologies-such as contact force sensing, irrigated-tip designs, and pulsed field ablation-are enhancing safety, accuracy, and efficacy, thereby facilitating increased adoption among electrophysiologists.

"On the basis of indication, the atrial fibrillation devices segment held the largest share in the electrophysiology market in 2024."

By product, the electrophysiology market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white (WPW) syndrome, and other indications. The expansion of the atrial fibrillation (AF) segment within the electrophysiology (EP) market is largely attributed to a convergence of demographic, lifestyle, clinical, and technological influences. The increasing global demographic of aging individuals, alongside rising rates of obesity, hypertension, diabetes, and sedentary behaviors, has led to a notable surge in AF prevalence. This growing burden of AF is driving heightened demand for EP diagnostics and therapeutic interventions. Moreover, significant advancements in EP procedural techniques, such as enhanced catheter ablation methods, state-of-the-art mapping systems, and sophisticated intracardiac imaging technologies, have markedly improved both the efficacy and safety profiles of interventions. These innovations are prompting clinicians to adopt ablation procedures earlier in the treatment continuum and with greater frequency, reflecting a paradigm shift in the management of AF.

"By region, North America accounted for the largest market share in 2024."

The electrophysiology sector in North America is experiencing robust expansion, primarily driven by the rising incidence of cardiac arrhythmias, notably atrial fibrillation. This trend correlates with an aging demographic and a high prevalence of comorbidities such as obesity, diabetes, and hypertension. Consequently, there is an escalating demand for advanced diagnostic and therapeutic electrophysiological procedures. Recent innovations-including 3D electro-anatomical mapping, enhanced radiofrequency and cryoablation technologies, and the introduction of pulsed-field ablation-have markedly improved procedural accuracy, patient safety, and clinical outcomes. These advancements are facilitating greater integration of electrophysiology practices within standard cardiology workflows.

"Asia Pacific to register the highest CAGR during the forecast period."

During the forecast period, the Asia Pacific (APAC) region is poised to experience considerable growth in the electrophysiology market. This region encompasses key markets such as India, China, Japan, Australia, South Korea, and Rest of Asia Pacific. The APAC electrophysiology market is witnessing a notable acceleration due to several interrelated factors. The escalating healthcare costs in major APAC countries-including China, India, Japan, and South Korea-are driving healthcare providers to adopt advanced medical technologies at an expedited pace. Enhanced healthcare infrastructure is facilitating this transition, allowing for greater accessibility to sophisticated electrophysiological devices. Moreover, the rising prevalence of cardiovascular diseases, attributable to demographic shifts such as aging populations, urbanization, and changing lifestyles, underscores the urgent need for effective diagnosis and treatment methodologies. Electrophysiology procedures, significantly relied upon for assessing and managing cardiac disorders, are consequently fueling demand for associated diagnostic and therapeutic devices within the region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
  • By Designation: C-level-27%, Director-level-18%, and Others-55%
  • By Region: North America-50%, Europe-20%, Asia Pacific-15%, Latin America-10%, and the Middle East & Africa-5%

Key players in the electrophysiology market are Johnson & Johnson Services, Inc.(US), Abbott (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Boston Scientific Corporation (US), Japan Lifeline Co., Ltd (Japan), Stereotaxis, Inc.(US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), Teleflex Incorporated (US), Acutus Medical, Inc. (US), Merit Medical Systems (US), OSYPKA MEDICAL (Germany), Cook (US), Epmap-System (Germany), CathRx Ltd. (Australia), EP Solutions (Switzerland), CathVision (Denmark), TZ Medical, Inc. (US), APN Health, LLC (US), Lepu Medical Technology(Beijing)Co., Ltd (China), CardioFocus (US), Schwarzer Cardiotek (Germany), and Imricor (US).

Study Coverage:

The report analyzes the electrophysiology market and aims at estimating the market size and future growth potential of this market based on various segments such as devices & consumables, cancer type, procedure, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall pressure monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers

  • The report studies the electrophysiology market based on product, indication, end user, and region
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
  • The report studies micro markets concerning their growth trends, prospects, and contributions to the global electrophysiology market.
  • The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants/smaller firms in this market with investment evaluation viability within the Electrophysiology market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, growth catalysts, challenges, and prospects, thereby empowering strategic decision-making with astute discernment.

The report provides insights on the following pointers:

  • Analysis of key drivers (technological innovations for advanced, effective, and easy-to-use electrophysiological devices; high geriatric population and increased prevalence of cardiovascular diseases; rising investments, funds, and grants for cardiac surgeries and electrophysiology; increasing cardiovascular disease incidence and procedural volume), restraints (high product cost and inadequate reimbursement in developing and under-resourced healthcare settings, unfavorable healthcare reforms in US); opportunities (substantial growth opportunities in emerging economies, popularity of ambulatory surgical centers offering cost-effective outpatient electrophysiology services), and challenges (global shortage of skilled and experienced personnel) influencing the growth of the electrophysiology market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the electrophysiology market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the Electrophysiology market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the electrophysiology market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Johnson & Johnson Services, Inc. (US), Abbott (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), and Boston Scientific Corporation (US), among others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Objectives of primary research
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Breakdown of primaries
      • 2.1.2.5 Key insights from primaries
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 REVENUE SHARE ANALYSIS
    • 2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)
    • 2.2.3 TOP-DOWN APPROACH (UTILIZATION RATE AND ADOPTION PATTERN)
    • 2.2.4 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
  • 2.3 GROWTH FORECAST
  • 2.4 DATA TRIANGULATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH IMITATIONS
    • 2.6.1 SCOPE-RELATED LIMITATIONS
    • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW
  • 4.2 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND COUNTRY
  • 4.3 ELECTROPHYSIOLOGY MARKET: REGIONAL MIX
  • 4.4 ELECTROPHYSIOLOGY MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • 4.5 ELECTROPHYSIOLOGY MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Technological innovations for advanced, effective, and easy-to-use electrophysiological devices
        • 5.2.1.1.1 Rising use of non-invasive cardiac mapping
        • 5.2.1.1.2 Increasing use of improved intracardiac ablation systems
        • 5.2.1.1.3 Rising use of MRI-guided ablation procedures
        • 5.2.1.1.4 Increasing ultrasound guidance in electrophysiology labs
      • 5.2.1.2 High geriatric population and increased prevalence of cardiovascular diseases
      • 5.2.1.3 Rising investments, funds, and grants for cardiac surgeries and electrophysiology
      • 5.2.1.4 Increasing cardiovascular disease incidence and procedural volume
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High product cost and inadequate reimbursement in developing and under-resourced healthcare settings
      • 5.2.2.2 Unfavorable healthcare reforms in US
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Substantial growth opportunities in emerging economies
      • 5.2.3.2 Popularity of ambulatory surgical centers offering cost-effective outpatient electrophysiology services
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Global shortage of skilled and experienced personnel
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 INTEGRATION OF DIGITAL TECHNOLOGIES, ARTIFICAL INTELLIGENCE, AND REMOTE MONITORING IN ELECTROPHYSIOLOGY
    • 5.3.2 ROBOTIC-ASSISTED ABLATION AND NAVIGATION TECHNOLOGIES FOR BETTER TRACTION IN ELECTROPHYSIOLOGY
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 3D mapping and navigation systems
      • 5.4.1.2 Cryoablation and radiofrequency ablation technologies
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Cardiac imaging technologies
      • 5.4.2.2 Robotic navigation systems
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 AI-enabled intravascular optical coherence tomography (OCT)
      • 5.4.3.2 AI-driven view guidance in intra-cardiac echocardiography (ICE)
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.5.2 BARGAINING POWER OF BUYERS
    • 5.5.3 BARGAINING POWER OF SUPPLIERS
    • 5.5.4 THREAT OF SUBSTITUTES
    • 5.5.5 THREAT OF NEW ENTRANTS
  • 5.6 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.6.2 KEY BUYING CRITERIA
  • 5.7 REGULATORY ANALYSIS
    • 5.7.1 REGULATORY FRAMEWORK
      • 5.7.1.1 North America
        • 5.7.1.1.1 US
        • 5.7.1.1.2 Canada
      • 5.7.1.2 Europe
      • 5.7.1.3 Asia Pacific
        • 5.7.1.3.1 Japan
        • 5.7.1.3.2 China
        • 5.7.1.3.3 India
      • 5.7.1.4 Latin America
        • 5.7.1.4.1 Brazil
      • 5.7.1.5 Middle East & Africa
        • 5.7.1.5.1 UAE
    • 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT PUBLICATION TRENDS FOR ELECTROPHYSIOLOGY MARKET
    • 5.9.2 LIST OF KEY PATENTS
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA FOR HS CODE 901890, 2020-2024
    • 5.10.2 EXPORT DATA FOR HS CODE 901890, 2020-2024
  • 5.11 PRICING ANALYSIS
    • 5.11.1 INDICATIVE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY KEY PLAYER, 2022-2024
    • 5.11.2 AVERAGE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY REGION, 2022-2024
  • 5.12 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.13 UNMET NEEDS & END-USER EXPECTATIONS
  • 5.14 VALUE CHAIN ANALYSIS
  • 5.15 SUPPLY CHAIN ANALYSIS
  • 5.16 ECOSYSTEM ANALYSIS
  • 5.17 CASE STUDY ANALYSIS
    • 5.17.1 JOHNSON & JOHNSON TO EXPAND CARTO SUITE AND LEVERAGE AI FOR DECISION SUPPORT, VISUALIZATION, AND REMOTE DATA SHARING
    • 5.17.2 ABBOTT TO INTRODUCE ENSITE OMNIPOLAR TECHNOLOGY (OT) FOR ORIENTATION-INDEPENDENT MAPPING WITH PRECISE SIGNAL CLARITY
    • 5.17.3 PHILLIPS TO LAUNCH KODEX-EPD SYSTEM FOR ENABLING HIGH-RESOLUTION ANATOMICAL AND ELECTRICAL MAPPING WITHOUT DIRECT CATHETER CONTACT
  • 5.18 ADJACENT MARKET ANALYSIS
  • 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.20 INVESTMENT & FUNDING SCENARIO
  • 5.21 IMPACT OF AI/GEN AI ON ELECTROPHYSIOLOGY MARKET
  • 5.22 IMPACT OF 2025 US TARIFF ON ELECTROPHYSIOLOGY MARKET
    • 5.22.1 KEY TARIFF RATES
    • 5.22.2 PRICE IMPACT ANALYSIS
    • 5.22.3 IMPACT ON COUNTRY/REGION
      • 5.22.3.1 North America
        • 5.22.3.1.1 US
      • 5.22.3.2 Europe
      • 5.22.3.3 Asia Pacific
    • 5.22.4 IMPACT ON END-USE INDUSTRIES
      • 5.22.4.1 Hospitals & clinics
      • 5.22.4.2 Ambulatory surgery centers

6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES
    • 6.2.1 3D MAPPING SYSTEMS
      • 6.2.1.1 Development of alternative technologies to limit market growth
    • 6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS
      • 6.2.2.1 Increasing public-private funding for developing advanced novel recording systems to augment market growth
    • 6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS
      • 6.2.3.1 Cost-effectiveness and technological advancements to spur segment growth
    • 6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS
      • 6.2.4.1 Rising lifestyle- and age-related disorders to drive adoption for cardiac disease treatment
    • 6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS
      • 6.2.5.1 High incidence of cardiovascular disorders and availability of technologically advanced equipment to boost market growth
    • 6.2.6 REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS
      • 6.2.6.1 Favorable reimbursement scenario to propel market growth
  • 6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS
    • 6.3.1 CRYOABLATION CATHETERS
      • 6.3.1.1 Therapeutic advantages and better clinical studies to drive market growth
    • 6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS
      • 6.3.2.1 Technologically-advanced and safer catheters to drive adoption among healthcare professionals
    • 6.3.3 MICROWAVE ABLATION (MWA) CATHETERS
      • 6.3.3.1 Smaller diameter antennas, faster procedure times, and larger heating zones to aid market growth
    • 6.3.4 LASER ABLATION CATHETERS
      • 6.3.4.1 Launch of technologically-advanced laser ablation catheters to drive adoption in healthcare settings
  • 6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
    • 6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
      • 6.4.1.1 Development of technologically-advanced fixed and steerable diagnostic catheters to favor market growth
    • 6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
      • 6.4.2.1 Advanced electrophysiology diagnostic catheters to improve patient outcomes and optimize surgical procedures
    • 6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
      • 6.4.3.1 Availability of advanced ultrasound catheters and focus on supportive regulatory frameworks to drive segment
  • 6.5 ELECTROPHYSIOLOGY ACCESS DEVICES
    • 6.5.1 LAUNCH OF ADVANCED ACCESS DEVICES TO ENHANCE EFFICIENCY DURING ABLATION CATHETER MAPPING AND POSITIONING
  • 6.6 OTHER ELECTROPHYSIOLOGY PRODUCTS

7 ELECTROPHYSIOLOGY MARKET, BY INDICATION

  • 7.1 INTRODUCTION
  • 7.2 ATRIAL FIBRILLATION
    • 7.2.1 DEVELOPMENT OF ADVANCED CARDIAC MAPPING SYSTEMS FOR EARLY DISEASE DIAGNOSIS TO DRIVE MARKET
  • 7.3 ATRIAL FLUTTER
    • 7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATING ATRIAL FLUTTER TO PROPEL MARKET GROWTH
  • 7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
    • 7.4.1 INCREASING EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR TREATMENT OF AVNRT TO AID MARKET GROWTH
  • 7.5 WOLFF-PARKINSON-WHITE (WPW) SYNDROME
    • 7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO AUGMENT MARKET GROWTH
  • 7.6 OTHER INDICATIONS

8 ELECTROPHYSIOLOGY MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS & CARDIAC CENTERS
    • 8.2.1 PRESENCE OF BETTER CATHETERIZATION AND ELECTROPHYSIOLOGY LABORATORIES IN HOSPITALS TO SUPPORT MARKET GROWTH
  • 8.3 AMBULATORY SURGERY CENTERS
    • 8.3.1 DEMAND FOR MINIMAL HOSPITAL STAYS AND HIGH INCIDENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET GROWTH
  • 8.4 OTHER END USERS

9 ELECTROPHYSIOLOGY MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 US to dominate North American electrophysiology market during forecast period
    • 9.2.3 CANADA
      • 9.2.3.1 Growing government research funding to support market growth
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Rising prevalence of atrial fibrillation and associated arrhythmias to propel market growth
    • 9.3.3 UK
      • 9.3.3.1 High geriatric population and rise in cardiac diseases to fuel market growth
    • 9.3.4 FRANCE
      • 9.3.4.1 Favorable government healthcare policies and schemes to support market growth
    • 9.3.5 ITALY
      • 9.3.5.1 Rising incidence of cardiovascular diseases to drive adoption of electrophysiology devices
    • 9.3.6 SPAIN
      • 9.3.6.1 Rising number of cardiac ablation procedures to drive adoption of electrophysoiology products
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 JAPAN
      • 9.4.2.1 Favorable reimbursement scenario and presence of universal healthcare policies to boost market growth
    • 9.4.3 CHINA
      • 9.4.3.1 Growing geriatric population and rising prevalence of cardiovascular diseases to favor market growth
    • 9.4.4 INDIA
      • 9.4.4.1 Favorable government healthcare initiatives to support market growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Increasing target disease burden and rising government funding to spur market growth
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Supportive government initiatives to drive market
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Modernization of healthcare facilities to propel market growth
    • 9.5.3 MEXICO
      • 9.5.3.1 Favorable investment scenario for medical device manufacturers to fuel market growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 Kingdom of Saudi Arabia
        • 9.6.2.1.1 Rising number of private hospitals and increasing government financial support to fuel market growth
      • 9.6.2.2 UAE
        • 9.6.2.2.1 High clinical demand, increased government investment, and technological progress to aid market growth
      • 9.6.2.3 Rest of GCC Countries
    • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ELECTROPHYSIOLOGY MARKET
  • 10.3 REVENUE ANALYSIS, 2020-2024
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Product footprint
      • 10.5.5.4 Indication footprint
      • 10.5.5.5 End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2024
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of startups/SMEs
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 R&D ASSESSMENT OF KEY PLAYERS
  • 10.10 COMPETITIVE SCENARIO
    • 10.10.1 PRODUCT LAUNCHES & APPROVALS
    • 10.10.2 DEALS
    • 10.10.3 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 JOHNSON & JOHNSON SERVICES, INC.
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches and approvals
        • 11.1.1.3.2 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 ABBOTT
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches
        • 11.1.2.3.2 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 MEDTRONIC
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product approvals
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 KONINKLIJKE PHILIPS N.V.
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Deals
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Right to win
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 GE HEALTHCARE
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product approvals and enhancements
        • 11.1.5.3.2 Deals
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Right to win
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses & competitive threats
    • 11.1.6 BOSTON SCIENTIFIC CORPORATION
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product approvals
        • 11.1.6.3.2 Deals
    • 11.1.7 JAPAN LIFELINE CO., LTD.
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
    • 11.1.8 STEREOTAXIS, INC.
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Product approvals
        • 11.1.8.3.2 Deals
    • 11.1.9 MICROPORT SCIENTIFIC CORPORATION
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product approvals
        • 11.1.9.3.2 Other developments
    • 11.1.10 BIOTRONIK
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Expansions
    • 11.1.11 TELEFLEX INCORPORATED
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Deals
    • 11.1.12 ACUTUS MEDICAL, INC.
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Product approvals
    • 11.1.13 MERIT MEDICAL SYSTEMS
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Deals
    • 11.1.14 OSYPKA MEDICAL
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
    • 11.1.15 COOK
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 EPMAP-SYSTEM
    • 11.2.2 CATHRX LTD.
    • 11.2.3 EP SOLUTIONS
    • 11.2.4 CATHVISION
    • 11.2.5 TZ MEDICAL, INC.
    • 11.2.6 APN HEALTH, LLC
    • 11.2.7 LEPU MEDICAL TECHNOLOGY (BEIJING) CO.,LTD.
    • 11.2.8 CARDIOFOCUS
    • 11.2.9 SCHWARZER CARDIOTEK
    • 11.2.10 IMRICOR

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ELECTROPHYSIOLOGY MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2021-2024 (UNIT OF USD)
  • TABLE 3 ELECTROPHYSIOLOGY MARKET: STUDY ASSUMPTIONS
  • TABLE 4 ELECTROPHYSIOLOGY MARKET: RISK ANALYSIS
  • TABLE 5 GLOBAL ANNUAL CARDIAC SURGICAL VOLUMES PER 100,000 POPULATION (2023)
  • TABLE 6 MAJOR FUNDING BY KEY ORGANIZATIONS, 2023-2024
  • TABLE 7 ELECTROPHYSIOLOGY MARKET: PORTER'S FIVE FORCES
  • TABLE 8 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • TABLE 9 KEY BUYING CRITERIA FOR ELECTROPHYSIOLOGY SYSTEMS
  • TABLE 10 US FDA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2024)
  • TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY
  • TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 ELECTROPHYSIOLOGY MARKET: CPT CODES
  • TABLE 19 ELECTROPHYSIOLOGY MARKET: LIST OF KEY PATENTS, 2025
  • TABLE 20 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 21 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 22 INDICATIVE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY KEY PLAYER, 2022-2024 (USD THOUSAND)
  • TABLE 23 AVERAGE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY REGION, 2022-2024 (USD THOUSAND)
  • TABLE 24 ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 25 ELECTROPHYSIOLOGY MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 26 CASE STUDY 1: JOHNSON & JOHNSON TO EXPAND CARTO SUITE FOR LEVERAGING AI FOR DECISION SUPPORT, VISUALIZATION, AND REMOTE DATA SHARING
  • TABLE 27 CASE STUDY 2: ABBOTT TO INTRODUCE ENSITE OMNIPOLAR TECHNOLOGY (OT) FOR ORIENTATION-INDEPENDENT MAPPING WITH PRECISE SIGNAL CLARITY
  • TABLE 28 CASE STUDY 3: PHILLIPS TO LAUNCH KODEX-EPD SYSTEM FOR ENABLING HIGH-RESOLUTION ANATOMICAL AND ELECTRICAL MAPPING WITHOUT DIRECT CATHETER CONTACT
  • TABLE 29 ELECTROPHYSIOLOGY MARKET: IMPACT OF AI/GEN AI
  • TABLE 30 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 31 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ELECTROPHYSIOLOGY PRODUCTS
  • TABLE 32 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 33 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 34 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 3D MAPPING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 RADIOFREQUENCY (RF) ABLATION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 42 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 CRYOABLATION CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 RADIOFREQUENCY (RF) ABLATION CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 COMPARISON BETWEEN RADIOFREQUENCY ABLATION AND MICROWAVE ABLATION (MWA) CATHETERS
  • TABLE 46 MICROWAVE ABLATION (MWA) CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 LASER ABLATION CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 49 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 52 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 56 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 58 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT), BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE (WPW) SYNDROME, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 62 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 64 ELECTROPHYSIOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 ELECTROPHYSIOLOGY MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023-2030 (UNITS)
  • TABLE 70 NORTH AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 71 NORTH AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 72 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 73 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 74 US: KEY MACROINDICATORS
  • TABLE 75 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 76 US: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 77 US: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 78 US: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 79 US: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 80 US: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 81 CANADA: KEY MACROINDICATORS
  • TABLE 82 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 83 CANADA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 84 CANADA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 85 CANADA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 86 CANADA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 87 CANADA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 88 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 89 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 90 EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 91 EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023-2030 (UNITS)
  • TABLE 92 EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 93 EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 95 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 96 GERMANY: KEY MACROINDICATORS
  • TABLE 97 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 98 GERMANY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 GERMANY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 100 GERMANY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 101 GERMANY: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 102 GERMANY: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 103 UK: KEY MACROINDICATORS
  • TABLE 104 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 105 UK: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 UK: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 107 UK: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 UK: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 109 UK: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 110 FRANCE: KEY MACROINDICATORS
  • TABLE 111 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 112 FRANCE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 113 FRANCE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 FRANCE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 FRANCE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 116 FRANCE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 117 ITALY: KEY MACROINDICATORS
  • TABLE 118 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 119 ITALY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 ITALY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 121 ITALY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 122 ITALY: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 123 ITALY: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 124 SPAIN: KEY MACROINDICATORS
  • TABLE 125 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 126 SPAIN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 127 SPAIN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 128 SPAIN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 129 SPAIN: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 130 SPAIN: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 131 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 132 REST OF EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 133 REST OF EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 134 REST OF EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 136 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023-2030 (UNITS)
  • TABLE 141 ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 145 JAPAN: KEY MACROINDICATORS
  • TABLE 146 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 147 JAPAN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 148 JAPAN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 149 JAPAN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 150 JAPAN: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 151 JAPAN: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 152 CHINA: KEY MACROINDICATORS
  • TABLE 153 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 154 CHINA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 CHINA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 CHINA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 157 CHINA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 158 CHINA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 159 INDIA: KEY MACROINDICATORS
  • TABLE 160 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 161 INDIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 INDIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 INDIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 164 INDIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 165 INDIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 166 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 167 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 168 AUSTRALIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 AUSTRALIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 170 AUSTRALIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 172 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 173 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 174 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 175 SOUTH KOREA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 176 SOUTH KOREA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 177 SOUTH KOREA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 178 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 179 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 180 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 184 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 186 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 187 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 188 LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 189 LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023-2030 (UNITS)
  • TABLE 190 LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 191 LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 193 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 194 BRAZIL: KEY MACROINDICATORS
  • TABLE 195 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 196 BRAZIL: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 197 BRAZIL: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 BRAZIL: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 199 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 200 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 201 MEXICO: KEY MACROINDICATORS
  • TABLE 202 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 203 MEXICO: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 MEXICO: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 205 MEXICO: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 MEXICO: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 207 MEXICO: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 208 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 209 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 213 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023-2030 (UNITS)
  • TABLE 218 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 229 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 230 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 232 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 233 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 234 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 235 UAE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 236 UAE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 237 UAE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 238 UAE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 UAE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 240 UAE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 241 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 242 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 243 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 244 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 245 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 246 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 247 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 248 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 249 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 251 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 252 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 253 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET
  • TABLE 254 ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION
  • TABLE 255 ELECTROPHYSIOLOGY MARKET: REGION FOOTPRINT
  • TABLE 256 ELECTROPHYSIOLOGY MARKET: PRODUCT FOOTPRINT
  • TABLE 257 ELECTROPHYSIOLOGY MARKET: INDICATION FOOTPRINT
  • TABLE 258 ELECTROPHYSIOLOGY MARKET: END-USER FOOTPRINT
  • TABLE 259 ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 260 ELECTROPHYSIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION
  • TABLE 261 ELECTROPHYSIOLOGY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 262 ELECTROPHYSIOLOGY MARKET: DEALS, JANUARY 2022-MAY 2025
  • TABLE 263 ELECTROPHYSIOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 264 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 265 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
  • TABLE 266 JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 267 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 268 ABBOTT: COMPANY OVERVIEW
  • TABLE 269 ABBOTT: PRODUCTS OFFERED
  • TABLE 270 ABBOTT: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 271 ABBOTT: DEALS, JANUARY 2022-MAY 2025
  • TABLE 272 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 273 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 274 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 275 MEDTRONIC: DEALS, JANUARY 2022-MAY 2025
  • TABLE 276 KONINKIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 277 KONINKIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 278 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 279 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 280 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 281 GE HEALTHCARE: PRODUCT APPROVALS AND ENHANCEMENTS, JANUARY 2022-MAY 2025
  • TABLE 282 GE HEALTHCARE: DEALS, JANUARY 2022-MAY 2025
  • TABLE 283 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 284 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 285 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 286 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022-MAY 2025
  • TABLE 287 JAPAN LIFELINE CO., LTD.: COMPANY OVERVIEW
  • TABLE 288 JAPAN LIFELINE CO., LTD.: PRODUCTS OFFERED
  • TABLE 289 STEREOTAXIS, INC.: COMPANY OVERVIEW
  • TABLE 290 STEREOTAXIS, INC.: PRODUCTS OFFERED
  • TABLE 291 STEREOTAXIS, INC.: PRODUCT APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 292 STEREOTAXIS, INC.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 293 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 294 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 295 MICROPORT SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 296 MICROPORT SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 297 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 298 BIOTRONIK: PRODUCTS OFFERED
  • TABLE 299 BIOTRONIK: EXPANSIONS: JANUARY 2022-MAY 2025
  • TABLE 300 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 301 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 302 TELEFLEX INCORPORATED: DEALS, JANUARY 2022-MAY 2025
  • TABLE 303 ACUTUS MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 304 ACUTUS MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 305 ACUTUS MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 306 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
  • TABLE 307 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
  • TABLE 308 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2022-MAY 2025
  • TABLE 309 OSYPKA MEDICAL: COMPANY OVERVIEW
  • TABLE 310 OSYPKA MEDICAL: PRODUCTS OFFERED
  • TABLE 311 COOK: COMPANY OVERVIEW
  • TABLE 312 COOK: PRODUCTS OFFERED
  • TABLE 313 EPMAP-SYSTEM: COMPANY OVERVIEW
  • TABLE 314 CATHRX LTD.: COMPANY OVERVIEW
  • TABLE 315 EP SOLUTIONS: COMPANY OVERVIEW
  • TABLE 316 CATHVISION: COMPANY OVERVIEW
  • TABLE 317 TZ MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 318 APN HEALTH, LLC: COMPANY OVERVIEW
  • TABLE 319 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW
  • TABLE 320 CARDIOFOCUS: COMPANY OVERVIEW
  • TABLE 321 SCHWARZER CARDIOTEK: COMPANY OVERVIEW
  • TABLE 322 IMRICOR: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 ELECTROPHYSIOLOGY MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 ELECTROPHYSIOLOGY MARKET: YEARS CONSIDERED
  • FIGURE 3 ELECTROPHYSIOLOGY MARKET: RESEARCH DESIGN
  • FIGURE 4 ELECTROPHYSIOLOGY MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 ELECTROPHYSIOLOGY MARKET: KEY PRIMARY SOURCES (SUPPLY AND DEMAND SIDES)
  • FIGURE 6 ELECTROPHYSIOLOGY MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 BREAKDOWN OF PRIMARIES (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8 BREAKDOWN OF PRIMARIES (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION
  • FIGURE 9 ELECTROPHYSIOLOGY MARKET: INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 10 ELECTROPHYSIOLOGY MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION (REVENUE SHARE ANALYSIS)
  • FIGURE 11 MARKET REVENUE ESTIMATION OF MEDTRONIC (2024)
  • FIGURE 12 ELECTROPHYSIOLOGY MARKET: SUPPLY-SIDE ANALYSIS
  • FIGURE 13 ELECTROPHYSIOLOGY MARKET: BOTTOM-UP APPROACH
  • FIGURE 14 ELECTROPHYSIOLOGY MARKET: TOP-DOWN APPROACH
  • FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ELECTROPHYSIOLOGY MARKET
  • FIGURE 16 ELECTROPHYSIOLOGY MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS), 2024
  • FIGURE 17 ELECTROPHYSIOLOGY MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 18 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 ELECTROPHYSIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 21 ELECTROPHYSIOLOGY MARKET: REGIONAL SNAPSHOT
  • FIGURE 22 RISING INCIDENCE OF CARDIOVASCULAR DISORDERS TO DRIVE MARKET
  • FIGURE 23 US AND ELECTROPHYSIOLOGY ABLATION CATHETERS ACCOUNTED FOR LARGEST NORTH AMERICAN MARKET SHARE IN 2024
  • FIGURE 24 ASIA PACIFIC TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 25 CHINA AND INDIA TO ACCOUNT FOR HIGHEST GROWTH RATES FROM 2025 TO 2030
  • FIGURE 26 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 27 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 28 ELECTROPHYSIOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 29 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • FIGURE 30 KEY BUYING CRITERIA FOR ELECTROPHYSIOLOGY END USERS
  • FIGURE 31 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR ELECTROPHYSIOLOGY PATENTS (JANUARY 2015-JUNE 2025)
  • FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR ELECTROPHYSIOLOGY PATENTS (JANUARY 2015-JUNE 2025)
  • FIGURE 33 ELECTROPHYSIOLOGY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 34 ELECTROPHYSIOLOGY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 35 ELECTROPHYSIOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 36 ADJACENT MARKETS TO ELECTROPHYSIOLOGY MARKET
  • FIGURE 37 ELECTROPHYSIOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 38 ELECTROPHYSIOLOGY MARKET: FUNDING AND NUMBER OF DEALS, 2021-2024
  • FIGURE 39 ELECTROPHYSIOLOGY MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 40 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT
  • FIGURE 41 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT
  • FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET (2020-2024)
  • FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET (2024)
  • FIGURE 44 ELECTROPHYSIOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 45 ELECTROPHYSIOLOGY MARKET: COMPANY FOOTPRINT
  • FIGURE 46 ELECTROPHYSIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 47 EV/EBITDA OF KEY VENDORS
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 49 ELECTROPHYSIOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 50 ELECTROPHYSIOLOGY MARKET: R&D ASSESSMENT OF KEY PLAYERS, 2022-2024
  • FIGURE 51 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
  • FIGURE 52 ABBOTT: COMPANY SNAPSHOT
  • FIGURE 53 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 54 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 55 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 56 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 57 JAPAN LIFELINE CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 58 STEREOTAXIS, INC.: COMPANY SNAPSHOT
  • FIGURE 59 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 60 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 61 ACUTUS MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 62 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT